<!DOCTYPE html>
<html lang="en">
  <head>
    <title>ORKAMBIâ„¢ (lumacaftor/ivacaftor) Webcast</title>
    <meta name="description" content="">
    <%= stylesheet_link_tag    "application", :media => "all" %>
    <%= javascript_include_tag 'application' %>
    <%= csrf_meta_tags %>
    <%= tag :meta, name: "viewport", content: "width=device-width, initial-scale=1.0" %>
    <!-- Cookie Script? -->
    <!-- <script src='http://ico-cookie-warning.googlecode.com/svn/trunk/ico_cookies.js'></script> -->
    <%= analytics_init if Rails.env.production? %>
    <%= favicon_link_tag 'favicon.ico' %>
  </head>
  <body>
  
  <div class="wrapper">
    <%= yield %>
    <!-- Modal to report AE -->
    <div class="modal fade" style="margin-top: 50px;" id="AEModal" tabindex="-1" role="dialog" aria-labelledby="myModalLabel" aria-hidden="true" data-keyboard="false" data-backdrop="static">
      <div class="modal-dialog" style="max-width: 500px; padding: 50px;">
        <div class="modal-content">
          <div class="modal-footer">
            <%= link_to "X", root_path %>
          </div><!-- /.modal-footer -->
          <div class="modal-body" style="text-align:left;">
            <h4>Reporting a suspected adverse event</h4>
            <br />
            <p>Any adverse event (AE), product complaint (PC) or other safety information associated with the use of a Vertex Pharmaceuticals Ltd. product should be reported to Vertex via phone +44 (0) 800 028 26116 or email <a href="mailto:vertexmedicalinfo@vrtx.com" style="text-decoration: underline !important;">vertexmedicalinfo@vrtx.com</a></p>
            <p><span style="font-weight: 400;">Adverse event</span><span style="font-weight: 300;"> is defined as any untoward medical occurrence in a patient administered a pharmaceutical product which does not necessarily have a casual relationship with the treatment, including any unfavorable or unintended signs od symptoms or disease temporarily associated with the use of a medical product.</span></p>
            <p><span style="font-weight: 400;">Product complaint</span><span style="font-weight: 300;"> is defined as any verbal or written communication of inquiry or dissatisfaction with the identity, strength, quality or purity of a released pharmaceutical product. In addition, suspected counterfeit/falsified product is considered a product complaint.</span></p>
            <p><span style="font-weight: 400;">Other safety information</span> <span style="font-weight: 300;">are reports of misuse/abuse, overdose, off-label use, medication errors including potential errors, lack of efficacy, transmission of infectious agents, occupational exposure, any drug exposure (maternal or paternal) during pregnancy and/or breastfeeding, or any use of falsified/counterfeit product.</span></p>
          </div><!-- /.modal-body -->
        </div><!-- /.modal-content -->
      </div><!-- /.modal-dialog -->
    </div><!-- /.modal -->
  </div><!-- /.wrapper -->
  </body>
</html>